IONS - IONIS PHARMACEUTICALS INC

QQQ $ 602.61 $ 4.22 (0.71 %)

DIA $ 463.04 $ 0.00 (0 %)

SPY $ 665.11 $ 2.94 (0.44 %)

TLT $ 90.76 $ -0.20 (-0.22 %)

GLD $ 387.41 $ 6.60 (1.73 %)

Previous Close

$ 72.39

Open

$ 71.42

Bid

$ 71.00 x 11

Ask

$ 72.33 x 1

Day's Range

$ 71.24 - $ 73.92

52 Week Range

$ 23.95 - $ 73.92

Volume

3,234,234

Average Volume

Market Cap

11.52B

Beta (5Y Monthly)

$ 0.69

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-30-2025	06-30-2025	10-Q
2	04-30-2025	03-31-2025	10-Q
3	02-19-2025	12-31-2024	10-K
4	11-06-2024	09-30-2024	10-Q
5	08-01-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	02-21-2024	12-31-2023	10-K
8	11-02-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-03-2023	03-31-2023	10-Q
11	02-22-2023	12-31-2022	10-K
12	11-09-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-04-2022	03-31-2022	10-Q
15	02-24-2022	12-31-2021	10-K
16	11-03-2021	09-30-2021	10-Q
17	08-04-2021	06-30-2021	10-Q
18	05-05-2021	03-31-2021	10-Q
19	02-24-2021	12-31-2020	10-K
20	11-04-2020	09-30-2020	10-Q
21	08-05-2020	06-30-2020	10-Q
22	05-06-2020	03-31-2020	10-Q
23	03-02-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-08-2019	06-30-2019	10-Q
26	05-09-2019	03-31-2019	10-Q
27	03-01-2019	12-31-2018	10-K
28	11-06-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q
30	05-07-2018	03-31-2018	10-Q
31	02-28-2018	12-31-2017	10-K
32	11-07-2017	09-30-2017	10-Q
33	08-09-2017	06-30-2017	10-Q
34	05-09-2017	03-31-2017	10-Q
35	03-01-2017	12-31-2016	10-K
36	11-09-2016	09-30-2016	10-Q
37	08-09-2016	06-30-2016	10-Q
38	05-05-2016	03-31-2016	10-Q
39	02-26-2016	12-31-2015	10-K
40	11-09-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Maintains Buy on Ionis Pharmaceuti...
10/08/2025 16:24:20

Needham analyst Joseph Stringer maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target from $7...

Oppenheimer Maintains Outperform on Ionis ...
10/08/2025 15:51:23

Oppenheimer analyst Jay Olson maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Outperform and raises the price target fr...

this-penumbra-analyst-turns-bullish-here-are-top-4-upgrades-for-wednesday

This Penumbra Analyst Turns Bullish; Here ...
10/08/2025 13:34:53

JP Morgan Upgrades Ionis Pharmaceuticals t...
10/08/2025 11:47:34

JP Morgan analyst Jessica Fye upgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Neutral to Overweight and raises the price t...

HC Wainwright & Co. Reiterates Buy on Ioni...
10/08/2025 10:18:14

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $...

Ionis Highlights Transformational RNA Medi...
10/07/2025 11:17:50

Two independent launches underway in less than nine months, with two more on track for 2026 Growing pipeline of wholly owned me...

Stifel Maintains Hold on Ionis Pharmaceuti...
10/06/2025 12:24:55

Stifel analyst Paul Matteis maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Hold and raises the price target from $43 t...

Goldman Sachs Upgrades Ionis Pharmaceutica...
09/26/2025 16:59:03

Goldman Sachs analyst Salveen Richter upgrades Ionis Pharmaceuticals (NASDAQ: IONS) from Sell to Neutral and raises the pric...

Morgan Stanley Maintains Overweight on Ion...
09/23/2025 18:03:46

Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price targ...

Barclays Maintains Overweight on Ionis Pha...
09/23/2025 13:58:04

Barclays analyst Gena Wang maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price target from ...

Guggenheim Maintains Buy on Ionis Pharmace...
09/23/2025 12:51:32

Guggenheim analyst Debjit Chattopadhyay maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target...

B of A Securities Maintains Buy on Ionis P...
09/23/2025 12:31:42

B of A Securities analyst Jason Gerberry maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price targe...

What Analysts Are Saying About Ionis Pharm...
09/23/2025 12:02:13

HC Wainwright & Co. Reiterates Buy on Ioni...
09/23/2025 10:56:42

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $...

ionis-pharmaceuticals-reveals-unprecedented-results-from-rare-neurological-disease-trial

Ionis Pharmaceuticals Reveals 'Unprecedent...
09/22/2025 13:06:58

Ionis reports positive pivotal study results for zilganersen in Alexander disease, showing gait speed benefits and strong safet...

Ionis Pharmaceuticals Shares Resume
09/22/2025 11:31:21

Trading Halt: Halt status updated at 7:25:...
09/22/2025 11:25:04

Ionis Pharmaceuticals Says Topline Results...
09/22/2025 11:07:18

First and only investigational medicine to demonstrate a clinically meaningful and disease-modifying impact on this rare, often...

The European Commission Approved Ionis Pha...
09/19/2025 11:04:29

The approval is based on positive data from the Phase 3 Balance study, in which TRYNGOLZA 80 mg demonstrated a statistically si...

Ionis Pharmaceuticals Marks 10 Years Of Su...
09/12/2025 11:05:29